Diagnostic Imaging Staff

Articles by Diagnostic Imaging Staff

The U.S. Food and Drug Administration (FDA) has cleared GE Healthcare’s SenoBright contrast enhanced spectral mammography (CESM) unit, the company announced on Thursday. The technology is designed to produce contrast-enhanced images of the breast using an x-ray contrast agent and a dual energy acquisition technique.

Toshiba American Systems Inc. today announced FDA clearance of their M-Power interface aimed at increasing MR exam efficiency. The customizable user interface enables technologists to streamline and accelerate the imaging process and enhance diagnosis, according to the company.

The mammography screening guidelines released in 2009 were more confusing than they were helpful, and women aged 40 to 49 were the most confused. That’s according to a study published in the May 2011 issue of the American Journal of Preventive Medicine, in which researchers examined news reports and social media posts about the new recommendations, as well as surveyed women after the announcement.

Interventional radiologists have confirmed the effectiveness of a liver cancer treatment that has shown results were chemotherapy has failed. Treating liver tumors with higher doses of intra-arterial yttrium-90 radioembolization, which can be done on an outpatient basis, was shown to be effective and help preserve the patient’s quality of life, according to a study presented this week at the Society of Interventional Radiology’s 36th annual scientific meeting in Chicago.

The Global Harmonization Task Force, which was created in 1992 to “achieve greater uniformity between national medical device regulatory systems,” decided recently to disband and reform without industry representatives. The group is comprised of the U.S. FDA and the regulatory bodies of the European Union, Japan, Canada, and Australia.